Table 1.
Data From Cirrhotic Patients and Healthy Volunteers
| Index | LC | HC |
|---|---|---|
| Age, y, means ± SD | 53.55 ± 9.03 | 52.35 ± 9.77 |
| Male/female | 23/8 | 17/3 |
| HBsAg, +/- | 26/5 | NA |
| ALT, U/L, means ± SD | 33.22 ± 13.84 | 19.1 ± 8.12 |
| AST, U/L, means ± SD | 39.97 ± 15.97 | 24.6 ± 9.42 |
| Albumin, g/L | 31.76 ± 7.41 | 40.41 ± 8.99 |
| TBIL, μmol/L | 16.62 ± 8.30 | 11.46 ± 3.96 |
| CRP, mg/mL | 7.75 ± 6.24 | 2.35 ± 3.02 |
| PT, % | 80.89 ± 16.17 | 76.28 ± 16.99 |
| Therapy treatment, resection/TACE/MCT | 15/13/3 | NA |
| Child–Pugh, A/B | 14/17 | NA |
CRP, C-reactive protein; HBsAg, hepatitis B surface antigen; HC, healthy control; LC, liver cirrhosis; MCT, microwave coagulation therapy; PT, prothrombin activity; TACE, transcatheter arterial chemoembolization; TBIL, total bilirubin.